Fei Quan
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Cancer, Lipids, and Metabolism 3
- Cancer-related molecular mechanisms research 3
Fei Quan
20 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 771
- Pulmonary and Respiratory Medicine 882
- Immunology 419
- Molecular Biology 1.2k
- Nephrology 92
Countries citing papers authored by Fei Quan
This map shows the geographic impact of Fei Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Quan more than expected).
Fields of papers citing papers by Fei Quan
This network shows the impact of papers produced by Fei Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Quan. The network helps show where Fei Quan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Quan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 29 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 5 | |
| 7 | ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury Hit paper breakdown → | 2022 | 307 |
| 8 | 2022 | 1 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 15 | |
| 11 | Quercetin alleviates acute kidney injury by inhibiting ferroptosis Hit paper breakdown → | 2020 | 464 |
| 12 | 2020 | 18 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 200 | |
| 15 | 2019 | 39 | |
| 16 | 2019 | 31 | |
| 17 | 2018 | 77 | |
| 18 | 2018 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2017 | 8 |
About Fei Quan
Fei Quan is a scholar working on Cancer Research, Biophysics, Complementary and alternative medicine, Neurology and Immunology, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ferroptosis and cancer prognosis (3 papers), Immune cells in cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Single-cell and spatial transcriptomics (2 papers), Mycobacterium research and diagnosis (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Cancer Research (771 citations), Pulmonary and Respiratory Medicine (882 citations), Immunology (419 citations), Molecular Biology (1.2k citations) and Nephrology (92 citations). Fei Quan has collaborated with scholars based in China, United States and Argentina. Frequent co-authors include Xinghua Gao, Qiuhua Cao, Chongxiu Yue, Yanting Lin, Ran Bi, Yong Yang, Yun Xiao, Jinyuan Xu, Hongbao Yang and Xia Li. Their work appears in journals such as European Journal of Pharmacology, Frontiers in Genetics, Nucleic Acids Research, Brain Research and Journal of Advanced Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.